Barré for every million doses given.
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according ...
“As of December 28, Oneida County has had 386 flu cases reported since the flu season began,” said Daniel W. Gilmore, Ph.D., ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...